Soo-kyung Jeong
R&D Center, Seongnam Si
Gyeonggi-do, Republic of Korea
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis.
Journal: Cell death & disease
Published: June 05, 2025
CXCR5 and TLR4 signals synergistically enhance non-small cell lung cancer progression.
Journal: Clinical and translational medicine
Published: August 24, 2023
The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner.
Journal: Cancer communications (London, England)
Published: March 12, 2023
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.
Journal: Cell & bioscience
Published: February 07, 2023
β-arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4.
Journal: Cell death & disease
Published: November 23, 2022
CRBN is downregulated in lung cancer and negatively regulates TLR2, 4 and 7 stimulation in lung cancer cells.
Journal: Clinical and translational medicine
Published: June 12, 2022
Stratifin (SFN) regulates lung cancer progression via nucleating the Vps34-BECN1-TRAF6 complex for autophagy induction.
Journal: Clinical and translational medicine
Published: March 21, 2022
USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction.
Journal: Cell death & disease
Published: September 08, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026